Reconstitution Required: Bacteriostatic Water needed for research peptide preparation (not for human use)

The Theramedix CJC-1295 (without DAC) + Ipamorelin blend is a dual-component investigational peptide formulation developed for use in advanced laboratory research environments.

CJC-1295 (without DAC) is a short-acting peptide analog discussed in scientific literature for its interaction with growth hormone–releasing hormone (GHRH) receptors, while Ipamorelin is a peptide analog studied for its selective interaction with ghrelin (GHSR) receptors.

In research settings, this combination has made the blend a subject of interest in studies examining peptide–receptor interactions, endocrine signaling models, and multi-peptide system behavior. Its formulation allows researchers to explore co-signaling dynamics and peptide compatibility within controlled in-vitro and analytical study frameworks.

Any references to hormonal pathways, signaling activity, or peptide interactions are provided solely for educational and laboratory context and do not imply therapeutic, physiological, or clinical outcomes.

This material is provided exclusively for laboratory research, analytical study, and in-vitro investigation.

Not for human or veterinary use. For research use only.